ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Synvista Therapeutics,

Synvista Therapeutics, (SYI)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

SYI Latest News

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series...

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

MONTVALE, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that, following a review of its clinical development portfolio and its...

Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium

MONTVALE, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has completed enrollment of its BENEFICIAL study, a Phase 2 double-blind...

Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance

Company Expects Its Common Stock to Remain Listed While it Engages in Compliance Process MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI...

Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline

Synvista Therapeutics Technology Provided CML Biomarker Data for Studies MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced...

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

MONTVALE, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has dosed the first patient in a 30-patient Phase 2 clinical trial of its proprietary...

Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit

MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX:SYI) today announced that it has submitted, and that the FDA has received its application for 510(k) clearance...

Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA M

New Data Presented at the Meeting Demonstrate Vitamin E May Help Prevent Cardiovascular Events in Hp2-2 Diabetes MONTVALE, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc...

Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

- Presentation to be Webcast - MONTVALE, N.J. , Nov. 10 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX:SYI) announced today that Noah Berkowitz, M.D., Ph.D., President and Chief...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATCHAtlasClear Holdings Inc
$ 0.3005
(56.02%)
131.7M
GNSGenius Group Limited
$ 1.11
(28.18%)
1.19M
KULRKULR Technology Group Inc
$ 0.2959
(17.23%)
5.53M
LODEComstock Inc
$ 0.5192
(16.81%)
4.3M
DITAMCON Distributing Co
$ 149.44
(10.00%)
13
TOVXTheriva Biologics Inc
$ 2.65
(-18.71%)
146.77k
KAPAKairos Pharma Ltd
$ 1.727
(-14.08%)
420.34k
PWPower REIT
$ 0.645
(-14.00%)
27.46k
HCWCHealthy Choice Wellness Corp
$ 2.7999
(-12.50%)
97.31k
VTAKCatheter Precision Inc
$ 0.4751
(-10.81%)
307k
ATCHAtlasClear Holdings Inc
$ 0.2985
(54.98%)
132.12M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 35.9352
(2.47%)
36.98M
FXIiShares China Large Cap
$ 29.745
(-2.15%)
36.75M
TELLTellurian Inc
$ 0.9602
(1.07%)
28.45M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 20.935
(-2.40%)
27.15M

Discussion

View Full Feed
Bountiful_Harvest Bountiful_Harvest 2 minutes ago
Markets are playing with fire on Israel invading Lebanon. This begins major shutdowns of trading passages, oil corridors, and brings multiple countries into battle. It’s 100x worse than Gaza.

Charts don't account for world war and the geopolitical landscape. Doesn't look like the cur
UVIX
linkvest linkvest 2 minutes ago
For 4s? lol
ASII
 just Scottie just Scottie 2 minutes ago
For sure
KITL
Acme Investments Acme Investments 2 minutes ago
I'm impressed this is still holding!! That means they are not dumping shares!! Zero liquidity is the only problem!!
HIRU
johny1 johny1 2 minutes ago
BTO SPY 568 P @ .17
TechandBio TechandBio 2 minutes ago
WVE Can't wait for the Phase 1 Obesity indication to commence later this year or early 2025 thats the icing on the cake.

$WVE
WVE
govprs govprs 2 minutes ago
I’m one of those on MERGER watch!
GDVM
Invest-in-America Invest-in-America 3 minutes ago
ATCH: Here's their CEO!!! (Just kidding, but can you believe this????)

https://www.youtube.com/watch?v=bz4yjlDccew
ATCH
STOCKMONSTER STOCKMONSTER 3 minutes ago
THE CULT LEADERS OF AI KEEP SAYING IN A FEWS YEARS!!!! IN A FEW YEARS BELIEVE ME MAN!!!! AI WILL CHANGE EVERYTHING!!!!! UNTIL THEN, AN WE HAVE SOME MORE OF YOUR CASH NOW!!!! MUAHAHAHAHAHA!!!!!!!!!!!!!!!
NVDA
stressfreeliving stressfreeliving 3 minutes ago
Congratulations. Your efforts will pay off.
ASII
trader_ron trader_ron 3 minutes ago
Rockin, glad I caught this.
ATCH
Strukture Strukture 3 minutes ago
KXIN scaling ;)
KXIN
researcher59 researcher59 3 minutes ago
NVDA (123) peaked in June at $140 intraday .... it's not linked to the broader market -

Since June 18th -
[pre]
TKR % Change Cur Price Start Price

$RUT 10% 2223.99 2025.23
$SPXEW 8% 7218.57 6679.99
$SPX
NVDA RUT SPX
Myth Myth 3 minutes ago
I Don't Know Why · Delaney & Bonnie w/ EC ( (Live at Royal Albert Hall 12/1/1969)

https://www.youtube.com/watch?v=WLI0XRRTDlc
SHMN
PENNY DIPZ PENNY DIPZ 3 minutes ago
45k in notes left as of yesterday, you’ll be the clown if you wait too long to re add after your flip.
SINC
TechandBio TechandBio 4 minutes ago
Just another day at the office!

What a year Viking, Summit, Wave, and Capricor those are my bios that hit so far!

$CAPR
CAPR
tombe tombe 4 minutes ago
Doesn’t “mirage” = false vision ?
ELTP
nit2win nit2win 4 minutes ago
Pretty sure real investors in Good Gaming, and I'll qualify that by saying anyone, unlike you, who actually own more than a share of stock, actually appreciate hearing from their CEO and in knowing that the company has a future game plan. Duh!
GMER
Seminole Red Seminole Red 4 minutes ago
got em all in, some real long shots
jbainseky jbainseky 4 minutes ago
Chart-wise, ln my opinion, we're headed south of double digits before the next leg up. News of any kind can change that of course.
FFTT
JBAIN
CDMO
manibiotech manibiotech 4 minutes ago
Here is chatGPT:

No, the FDA does not require large-scale manufacturing to be fully operational before approving a novel drug. However, the FDA does require that drug developers demonstrate the ability to consistently produce the drug according to regulatory standards.

NWBO
getReady getReady 4 minutes ago
Not at all, as all are waiting.
ASII
Diamondhands45 Diamondhands45 4 minutes ago
Action looks like dogshit IMO. Where is the buy volume with huge contacts and revenues imminent.

The lack of buying and substantial news only feeds the clowns narrative.

If they dropped news and we skyrocketed they would disappear like rats during a thunderstorm.
SPZI
Invest-in-America Invest-in-America 4 minutes ago
ATCH: Here's their CEO!!! (Just kidding, but can you believe this????)

https://www.youtube.com/watch?v=bz4yjlDccew
ATCH

Your Recent History

Delayed Upgrade Clock